Related Experiment Video
Updated: Oct 19, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Juvenile-onset open-angle glaucoma - A clinical and genetic update
Harathy Selvan1, Shikha Gupta1, Janey L Wiggs2
1Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Juvenile-onset open-angle glaucoma (JOAG) affects young adults, often linked to myocilin mutations and high intraocular pressure. Early detection and management are crucial for preventing vision loss in this progressive eye condition.
Area of Science:
- Ophthalmology
- Genetics
- Medical Science
Background:
- Juvenile-onset open-angle glaucoma (JOAG) is a form of primary open-angle glaucoma diagnosed before age 40.
- It can be familial or non-familial, with myocilin mutations being a common genetic association.
- JOAG presents with elevated intraocular pressure (IOP), often requiring surgical intervention.
Purpose of the Study:
- To summarize the key characteristics, pathophysiology, and management of juvenile-onset open-angle glaucoma.
- To highlight the importance of early diagnosis and lifelong monitoring in JOAG patients.
- To discuss the potential of emerging gene-based therapies for JOAG.
Main Methods:
- Review of existing literature on juvenile-onset open-angle glaucoma.
- Analysis of clinical presentation, genetic associations, and pathological mechanisms.
- Evaluation of current and future treatment strategies.
Main Results:
- JOAG is characterized by high IOP, male preponderance, and frequent association with myopia.
- Pathophysiology involves immaturity of conventional outflow pathways.
- Optic nerve head features include large discs with significant cupping due to high IOP-induced damage.
Conclusions:
- JOAG progression rates are similar to adult glaucomas, but the earlier onset leads to higher projected disability.
- Prompt management, early diagnosis, and continuous monitoring are vital for preventing disease progression.
- Gene-based therapies represent a promising future direction for JOAG treatment.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

